Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis
Open Access
- 12 February 2015
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 9 (4) , 1772-1778
Abstract
Cancer and embryo expression protein 65 (CEP65) is a centrosomal protein that is expressed at relatively high levels in embryonic tissue and different cancerous tissues, but its role in tumorigenesis remains unknown. In the present study, CEP65 was stably expressed in AGS gastric cancer cells. CEP65 was found to promote cell growth in the MTT assay and to enhance cell migration and invasion in Transwell chamber assays. To validate results from the in vitro experiments, CEP65 was stably expressed in BICR‑H1 breast cancer cells through adenovirus‑mediated transduction. By inoculating BICR‑H1 cells on chick chorioallantoic membrane (CAM), it was found that CEP65 promotes cell growth on the CAM and increases cell metastasis to the lungs of the chicken. By utilizing a xenograft severe combined immunodeficiency mouse model, CEP65 was also found to accelerate BICR‑H1 cell growth and metastasis to the lungs. Furthermore, it was shown that CEP65 increases matrix metalloproteinase (MMP)2 activity in zymographic assays, however, microarray screening and reverse transcription polymerase chain reaction validation revealed that CEP65 had no effect on the expression levels of MMP2 or MMP9, but decreased the expression levels of metastasis‑associated genes, TIMP2, RAP and VTN. Taken together, the results of the present study demonstrated the oncogenic function of CEP65 in promoting cancer cell growth and metastasis.Keywords
This publication has 34 references indexed in Scilit:
- Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer CellsPLOS ONE, 2013
- Vitronectin–αvβ3 Integrin Engagement Directs Hypoxia-Resistant mTOR Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer CellsCancer Research, 2013
- The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4Nature Genetics, 2006
- Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignanciesOncogene, 2005
- TIMP-2: an endogenous inhibitor of angiogenesisTrends in Molecular Medicine, 2005
- Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN geneCancer Letters, 2004
- Endometase/Matrilysin-2 in Human Breast Ductal Carcinoma in Situ and Its Inhibition by Tissue Inhibitors of Metalloproteinases-2 and -4Cancer Research, 2004
- Integrin αvβ3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer CellsJournal of Biological Chemistry, 2001
- Molecular Cloning of a Tumor-Associated Antigen Recognized by Monoclonal Antibody 3H11Biochemical and Biophysical Research Communications, 2001
- Radioimmunoguided surgery in gastric cancer using 131-I labeled monoclonal antibody 3H11Seminars in Surgical Oncology, 1994